For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Using vaccination conversations to empower and engage adolescents
Using vaccination conversations to empower and engage adolescents

This article emphasises why conversations with young people about vaccines must be a priority in general practice
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. Burman C, Serra L, Nuttens C, et al. Meningococcal disease in adolescents and young adults: a review of the rationale for prevention through vaccination. Hum Vaccin Immunother 2019;15(2):459–69.
2. Nowlan M. Review of evidence to inform New Zealand National Immunisation Programme, 2023: Human papillomavirus. IMAC; August 2023.
3. Cameron RL, Palmer TJ, Cuschieri K, et al. Assessing real world vaccine effectiveness: A review of Scotland’s approach to monitoring human papillomavirus (HPV) vaccine impact on HPV infection and cervical disease. Vaccine 2024;42(21):126177.